Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study

• Published in: PloS one Vol. 9; no. 11; p. e113399
• Main Authors: Kristensen, Søren Lund, Galløe, Anders M, Thuesen, Leif, Kelbæk, Henning, Thayssen, Per, Havndrup, Ole, Hansen, Peter Riis, Bligaard, Niels, Saunamäki, Kari, Junker, Anders, Aarøe, Jens, Abildgaard, Ulrik, Jeppesen, Jørgen L
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 19.11.2014; Public Library of Science (PLoS)
• Subjects: Age; Aged; Angina; Angina, Stable - complications; Aspirin; Biology and Life Sciences; Cardiology; Cardiovascular disease; Clinical medicine; Clopidogrel; Cohort Studies; Consortia; Coronary vessels; Drug-Eluting Stents - adverse effects; Electrocardiography; Female; Follow-Up Studies; Heart attacks; Hospitals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - chemistry; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Implantation; Implants; Logistic Models; Male; Medicine and Health Sciences; Middle Aged; Myocardial infarction; Myocardial Infarction - etiology; Odds Ratio; Patients; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors - chemistry; Platelet Aggregation Inhibitors - therapeutic use; Polymers; Risk; Statins; Stents; Studies; Surgical implants; Thromboembolism; Thrombosis; Thrombosis - complications; Thrombosis - therapy; Ticlopidine - analogs & derivatives; Ticlopidine - chemistry; Ticlopidine - therapeutic use; Denmark

The widespread use of coronary stents has exposed a growing population to the risk of stent thrombosis, but the importance in terms of risk of ST-segment elevation myocardial infarctions (STEMIs) remains unclear. We studied five years follow-up data for 2,098 all-comer patients treated with coronary...